Drug Company

Aug 29, 2015 at 15:46 | Source: PTI
The approval by the US FDA for Raloxifene Hydrochloride tablets is for strength of 60 mg, which is bio and therapeutically equivalent to the reference listed drug product (RLD) Evista, 60 mg of Eli Lilly, the company said in a statement.
Aug 27, 2015 at 18:01 | Source: PTI
The company has received final approval for its Omeprazole delayed-release capsules (40 mg) from the United States Food and Drugs Administration (USFDA), Lupin Ltd said in a statement.
Aug 27, 2015 at 13:39 | Source: PTI
The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Entecavir tablets in strengths of 0.5mg and 1mg, Aurobindo Pharma said in a statement.
Aug 27, 2015 at 13:28 | Source: Moneycontrol.com
"The company has received the final approval from the USFDA to manufacture and market Entecavir Tablets, 0.5mg and 1mg," it said in a filing to the exchange.
Aug 26, 2015 at 10:46 | Source: Moneycontrol.com
Credit Suisse has maintained neutral rating on the company in its report.
Aug 25, 2015 at 21:38 | Source: PTI
The company denied that US Food and Drug Administration has put any restriction on import of Dabur's product in market and would not impact its business there, Dabur said in a filing to the BSE. "USFDA had not put any restriction on import and sale in the US, of products manufactured at Dabur's Alwar unit".
Aug 25, 2015 at 20:29 | Source: PTI
Apart from Austral Coke & Projects and Dunlop India, trading would also be suspended in Alpha Graphic India, Central Provinces Railways Company, DSJ Communications, Lifeline Drugs & Pharma and SMS Techsoft (India) Ltd among others.
Aug 24, 2015 at 13:03 | Source: Moneycontrol.com
Aarey Drugs & Pharmaceuticals Ltd has informed that the Annual General Meeting of the Company will be held on September 25, 2015.
Aug 21, 2015 at 13:35 | Source: Moneycontrol.com
Aarti Drugs Ltd has submitted to BSE a copy of the details of the proceedings of 30th Annual General Meeting of the Company held on August 14, 2015.
Aug 20, 2015 at 18:33 | Source: PTI
The company has received final approval from the US Food and Drug Administration (USFDA) to market generic version of Teva's Fenofibrate tablets in strengths of 54mg and 160mg, Lupin said in a statement.
Messages on Drug Company »


Gold Member


Dr Reddys Labs  

The US market continues to drive growth for Dr Reddy`s and other Indian generic drug companies. What if this paradigm changes in the global context? The US drives the growth but we have to diversify our sources of growth even though the relative importance of the US may not change. Emerging markets

8.53 PM Jun 30th 2014

anil patil

Platinum Member


Aurobindo Pharm  

deal details with the stock exchanges showed. Morgan Stanley Asia Singapore, which is a shareholder of Aurobindo Pharma, sold 17,32,500 shares of the drug company for about Rs 670 apiece, valuing the transaction at Rs 116 crore. Morgan Stanley Asia Singapore held 46.16 lakh shares of Aurobindo Pharma

11.48 AM May 31st 2014


Platinum Member


Dishman Pharma  

Dishman Pharma is likely to move to UC after 28.05.2014. This drug company will find support at Rs.125/- on account of excellent results. Your best time to pick up this stock at the bottom fishing zone.

8.43 PM May 26th 2014


New Member



Drug Policy Control Order (DPCO) put a cap on the prices of 348 essential drugs, is likely to impact domestic revenue generation of both homegrown and multinational drug companies in 2014

12.55 PM May 15th 2014


Platinum Member



, according to data tracker Dealogic. Many drug companies have paid down debt taken on during a buying spree in the earlier 2000s and are now generating lots of cash they want to put to work. Prescription drug makers are also attracted to acquisitions because deals can allow them cut costs and scale back

4.02 PM Apr 22nd 2014


New Member


Aurobindo Pharm  

...so buy , rather accumulate Auro even at current levels for a 1-2 year timeframe. these US legalities are nothing new to Indian drug companies,happens all the time !

10.06 AM Apr 17th 2014

Web Messenger

Platinum Member


Sun Pharma  

Source:VC Circle - Sun Pharmaceutical Industries Ltd, the country's top drugmaker by market cap, is acquiring Ranbaxy Laboratories Ltd in an all-stock transaction, creating the world's fifth-largest generics drug company and the largest pharma company in India by far

12.10 PM Apr 8th 2014


Platinum Member


Sun Pharma  

Is it patent dispute with Drug company UCB?

9.16 PM Mar 18th 2014


Gold Member


Vivimed Labs  

I am doctor by profession and knows the value of research and upcoming drugs. COMPANY has spent lot of rs in research and next quarter filing new ADNA / molecules which will drive the earning. you see almost 90% of shares are by institutes or large investor.

12.47 PM Mar 18th 2014

Web Messenger

Platinum Member



Source:Calcutta Telegraph News - Mumbai, Feb. 20: Cipla has entered into an agreement with MSD to market the latter’s anti-HIV drug raltegravir in the country. This is the first time that Cipla is entering into a strategic partnership with a multinational drug company. MSD is the trade name

2.10 PM Feb 21st 2014

News across the web »
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.